Objective: Cardiac hypertrophy due to pressure overload is associated with several cellular electrophysiological alterations such as prolongation of action potential duration (APD), decrease in transient outward current (I ) and occurrence of the pacemaker current I .
1. Introduction in heart failure patients remains high. Recently, the ELITE study reported that treatment of elderly heart failure Sudden death due to ventricular arrhythmias is a major patients with the type-1 angiotensin II receptor (AT ) 1 risk factor in patients with myocardial hypertrophy and antagonist losartan was unexpectedly able to reduce morfailure [1] [2] [3] . Despite optimal medical treatment, mortality tality by lowering the incidence of sudden deaths [4] . In order to gain insight into the mechanism by which losartan exerts its favorable effect, we planned to study the effect of genetic model of chronic hypertension, progressively de-ACE inhibitors affect both the angiotensin and bradyvelop myocardial hypertrophy, whose severity increases kinin pathways. The availability of AT antagonists will 1 with aging and finally evolves toward failure [5] . In disclose the importance of angiotensin II in the progression middle-aged SHR the incidence of ventricular arrhythmias of these alterations. For all these reasons, we thought it (VAs) is higher than in age-matched normotensive rats, and would be interesting to assess the effect of long-term can be significantly reduced by long-term treatment with treatment with losartan, a selective AT antagonist, on the 1 angiotensin-converting enzyme inhibitors (ACE-I) [6, 7] . electrophysiological alterations occurring in SHR during The reduction in VAs seems to be correlated with the the development of severe cardiac hypertrophy. To this regression of both myocardial hypertrophy and fibrosis aim, we studied cell capacitance (an index of cell size), [6, 7] . Indeed, recent evidence suggests an important role of action potential, and membrane currents (I and I ) from to f angiotensin II produced within the myocardium in regulatleft ventricular myocytes isolated from the heart of 18-ing fibroblast collagen turnover [8] and in contributing to month old SHR after 8-week of treatment with saline or cardiac myocyte hypertrophy [9] [10] [11] .
losartan. Preliminary data have been published in abstract However, structural changes occurring in the hyperform [22] . trophied myocardium are not the only factors involved in the increased propensity of the hypertrophied heart to arrhythmias. Myocyte hypertrophy is a process always 2. Methods accompanied by cellular phenotypic alterations [12] . Development of cellular hypertrophy is associated with 2.1. Experimental design changes in the cellular electrophysiological properties of cardiac myocytes. These alterations have been widely Twenty-four spontaneously hypertensive (SHR) male studied in ventricular myocytes isolated from the hyrats of 16 months (Charles River, Italy) were kept in our pertrophied heart of SHR and other animal models of animal facility; 12 of them were given 10 mg / kg / day hypertrophy and failure as well as in myocytes isolated losartan (losartan-treated group) dissolved in tap water for from human failing hearts [13] . The most common electro-8 weeks; a control group of 12 rats received only tap water physiological alteration observed in the hypertrophied or during the same period of time, that is, until the age of 18 failing myocyte is the prolongation of action potential months. duration. This phenomenon appears to be due to a selective
The water consumption by each animal was measured reduction in the transient outward current I , and has been twice a week, and the amount of drug dissolved in drinking to clearly documented both in myocytes isolated from 18-water adjusted, in order to keep the daily dosage at 10 month old SHR [13] and in myocytes isolated from the mg / kg / day. At the end of treatment, systolic blood failing human heart [14] [15] [16] . Another electrophysiological pressure was measured using a tail-cuff system (Basile, alteration recently described both in human and in rat Italy). Despite the fact that systolic blood pressure was hypertrophied myocytes (the latter isolated from the left measured in only five animals for each group, and not ventricle of the 18-month old SHR) is the overexpression routinely, due to the high risk that old SHR may die when of an inward current having the characteristics of the submitted to the stress of manipulation, previous studies pacemaker current I [17] [18] [19] [20] . These cellular electrophyhave clearly documented that losartan 10 mg / mg / day has f siological alterations are likely to contribute to the ina modest antihypertensive effect in SHR [23, 24] ; this is the creased propensity of the hypertrophied or failing human case in our study as well. heart to life-threatening arrhythmias [16, 19] Single left ventricular myocytes were isolated from ACE inhibitors is able to reduce the development of control or losartan treated SHR using a protocol based on hypertrophy and fibrosis as well as to reduce the incidence previously described procedures [14, 17] . Rats were inof spontaneous or induced arrhythmias [6, 7] . Recently it jected with 500 I.U heparin i.p., anesthetized with ether has been reported that treatment of SHR with captopril is and decapitated. After thoracotomy, the heart was rapidly able to influence the cellular electrophysiological propexcised, weighed, mounted in a Langendorff apparatus and erties of isolated cells, in that the prolongation of action perfused for 20 min with a low-calcium solution (LCS, see potential duration is prevented [21] .
Solutions) prewarmed to 378C and equilibrated with 100% Free Fraction V, Serva, Italy) for 25-30 min. The left 7.2; pCa 7.0). ventricle and the septum were removed with fine scissors, minced and the pieces were stirred in the LCS. Car-2.5. Data analysis and statistics diomyocytes that appeared in the supernatant were purified by gravity sedimentation, collected and stored in LCS at Data analysis and fitting were performed by using the room temperature. The isolated cells were kept at room program Origin 4.1 (MicroCal Software Inc., MA, USA) temperature in LCS, supplemented with 1 mM CaCl and 2 running on a Pentium personal computer. For fitting 4% penicillin / streptomycin (Gibco BRL, Italy) and used functions, non-linear models of convergence to solutions within the day.
were used. Action potentials were elicited at a rate of 0.2 Hz and 2.3. Electrophysiological recordings sampled at 2 kHz. Depolarizing steps (700 ms) to positive potentials activated a 4-aminopyridine-sensitive outward Cells were placed in an experimental bath on the current, which was composed of transient and steady-state platform of an inverted microscope (Nikon Diaphot TMD, component, as already described in rat ventricular Japan). The patch-clamp technique (whole cell recording) myocytes [14] . Outward currents were evoked by steps in was used to measure electrophysiological properties of the the range of 240 to 170 mV from a HP of 270 mV isolated myocytes. Experiments were performed using a (sampling rate: 5 kHz); a pre-step to 240 mV was used to patch amplifier (Axopatch-1B, Axon Instruments, CA, inactivate sodium current. Series resistance and membrane USA) interfaced to a 486 personal computer by means of a capacitance were compensated in order to minimize the DAC /ADC interface (Labmaster Tekmar, Scientific Solucapacitive transient. I was measured as peak outward to tions, USA). Data were viewed on-line on an analogic current at the beginning of the depolarizing step, and oscilloscope and on a computer screen. Experimental normalized with respect to the membrane capacitance control, data acquisition and preliminary analysis were value (see below) [14] . Steady-state currents were meaperformed by means of the integrated software package sured at the end of the depolarizing steps. pClamp (Axon Instruments, CA). Cells were superfused I was defined as a time-dependent, hyperpolarizationf with normal Tyrode's solution or with Tyrode's solutions activated inward current completely and reversibly blocked properly modified to measure the transient outward current by adding 4 mM CsCl to the extracellular solution [17] . I f (I ) and the hyperpolarization-activated inward current (I ) to f was evoked by hyperpolarizing steps in the range of 260 (see Solutions). Temperature was maintained in the range to 2140 mV from a HP of 240 mV (sampling rate: 0.5 of 36-378C. Patch-clamp pipettes, prepared from glass kHz); the duration of the step was decreased (from 3200 to capillary tubes (Garner Glass Co., CA, USA) by means of 1600 ms) as the activation became progressively faster. To a two-stage vertical puller (Hans Otchoski, Homburg, evaluate steady-state values of the hyperpolarization-actiGermany), had a resistance of 1.5-2.5 MV when filled vated current, data were fitted to an exponential decay. with the internal solution (see Solutions). The patchCurrent amplitudes were measured as the difference beclamped cell was superfused by means of a temperaturetween the value at steady state and that at the beginning of controlled micro-superfusor, which allowed rapid changes the test pulse, and normalized with respect to the memin the solution bathing the cell. losartan-treated rats (P,0.05). At least part of the reduc-R 5 S I peak tion in cardiac hypertrophy appears to be due to a decreased cell size. This is shown in Fig. 1 , where the and distribution of membrane capacitance in the control and t ] C 5 treated groups is reported. Cell membrane capacitance is a m R S good index of cell dimension; it can be appreciated that the where I is the maximum level of current (relative to the two cell populations (96 cells from control and 92 from peak holding current) following the depolarization and t is the losartan-treated) have a different distribution. The cells time constant of the exponential current decay. The isolated from the heart of rats treated with losartan show a membrane capacitance values obtained have been used to distribution toward the smaller dimensions, the mean value compute ionic current densities (I and I density in being 342611.6 vs. 422613.9 pF in the control group.
to f pA/pF). These data are consistent with our previous results in SHR All data are expressed as mean6standard error of the and normotensive WKY rats, in which the cell capacitance mean (S.E.M.). Statistical analysis was performed by measurement nicely reflected the degree of cell hypermeans of the Graph Pad Instat program, using the Manntrophy. Whitney test (non-parametric test) for comparing mem- Fig. 2 shows representative action potentials recorded brane capacitance values, and Student's t-test for grouped data (two-sided P value) for all other values. A probability value of less than 0.05 was considered significant.
Results
The dose of losartan (10 mg / kg / day) was chosen on the basis of literature data, showing that this dose causes a modest reduction in blood pressure, but significantly reduces cardiac hypertrophy [23, 24] . The data have been confirmed in our study: in five rats for each group we responsible for the prolongation of action potential duration in hypertrophied myocytes in SHR [14] . In order to assess the ionic basis of the effect of losartan on action potential duration, we studied the characteristics of I . to As shown in Fig. 4 , the density of I was larger in to myocytes from losartan-treated animals. The peak outward currents were larger following the protocol (see inset) used to elicit I . This finding was confirmed by the current- pA / pF in control rats (P,0.02); the midpoint and slope of duration at 220 and 260 mV, respectively. losartan-treated rats (P,0.02). The representative recordfinding of this study is that blockade of AT not only 1 ings show that the current is clearly reduced to all affects development of cardiac and cellular hypertrophy, voltages; this is even more evident from the mean currentbut also affects the electrophysiological alterations, which voltage relationship. The activation of the current was not characteristically occur in the hypertrophied myocyte. To modified by the treatment, V and k being, respectively, our knowledge, this is the first demonstration that chronic 
Discussion
18-weeks old at the end of treatment, in which the development of hypertrophy is at its early stages and In the present study we evaluated the effect of chronic evaluating only the effect on APD and (for captopril) on treatment with losartan on the electrophysiological altera-I . Our results have been obtained in old SHR, that is in to tions occurring in old SHR, i.e. during a phase of their life animals in which cardiac hypertrophy is already severe and during which the development of severe cardiac hyperthe electrophysiological alterations (such as the action trophy occurs. SHR is a widely used model for left potential prolongation) already well-established [14] . We ventricular hypertrophy; the old SHR may better mimic the studied the effect of AT blockade on APD, I and on the found in myocytes isolated from the old SHR have been is capable of stimulating cardiac growth [37] and that found also in myocytes isolated from the failing human component of the cardiac RAS are independently and heart [19, 20] . Taken together, our data suggest that an differentially regulated by mechanical stretch and an-8-week treatment with losartan is able to counteract all giotensin II in neonatal cardiac myocytes [38] . On the these electrophysiological alterations when they are alwhole, the activation of the RAS is certainly playing an ready established, and that this could occur also in human important role, which, however, requires better understandwith obvious and important therapeutic implications. The ing [39] . present data, however, do not permit to definitely conclude
The present results add novel information on the effect that losartan causes a true regression, i.e. at the level of of pharmacological treatment on electrophysiological reage-matched normotensive rats, of the electrophysiological modeling, showing for the first time that AT blockade 1 remodeling associated with hypertrophy, rather than blockwith losartan is able to influence the electrophysiological ing the progression of the phenomenon. In fact, we lack alterations associated with cardiac and cellular hyperexperimental data in SHR at 16 month of age and trophy; they also suggests an important role of angiotensin historical data show a large variability in many parameters.
II depend on cell size [18, 27] . It is not present in normal responsible for altered in action potential configuration, myocytes and its density is directly related to the severity support such a view. Our results indeed clearly demonof hypertrophy [18] . 18 month-old SHR show a mean strate that action potential duration is shorter in losartanvalue of I density of 48 pS / pF (range: 35.3-54.4 pS / pF treated myocytes, and that this effect is due to a greater I f to [17, 18, 28] ), being 54.2 pS / pF in the present study. Losarand possibly I . We [14] have previously demonstrated that K tan-treated 18-month old SHR have an I density of 28.6 the main ionic alteration responsible for action potential f pS / pF, a value which is lower than that found in all SHR prolongation caused by chronic hypertension is a specific of the same age we have used, and similar to that found in decrease in I , the other currents influencing repolarization to historical age-matched WKY (20-21 pS / pF [18, 28] I to assess the effect of losartan on electrophysiological major determinants in influencing action potential duration to remodeling. In so doing, a regression of electrophysiologiin cardiac hypertrophy [13] . Thus, it may be speculated cal alterations toward age-matched control by chronic that chronic exposure of ventricular myocytes to angiotentreatment with losartan can be hypothesized. Studies in sin II, as probably occurs in hypertension, may cause a progress will clarify this point.
decrease in I channel expression, and that blockade of the to Interestingly, the effect of losartan was observed for a RAS system by ACE-inhibitors or blockers of AT re-1 daily dosage, which does not significantly affect systolic ceptors may antagonize this phenomenon. The electroblood pressure. This is not surprising since regression of physiological changes in action potential duration, I and to cardiac hypertrophy in the absence of significant lowering I observed in the present study are likely independent of K of blood pressure has been reported for both ACE-indirect electrophysiological effects of losartan or its active hibitors and AT antagonists [23, 26, 29, 30] . However, metabolite (E3174), taking into account the recently 1 many other studies failed to show a regression in cardiac reported actions of these compounds on potassium currents hypertrophy in the absence of lowered blood pressure [41] . [31] [32] [33] [34] . The reasons for such discrepancies are not Losartan-treated myocytes also show an I current of f obvious, but are possibly the consequences of the different smaller amplitude than saline-treated rats. The pacemaker models of cardiac hypertrophy used; in fact cardiac current I is physiologically present in pacemaker cells f hypertrophy appears to encompass more than one pheno- [42] ; in rat ventricular myocytes it is expressed during the type, even at the cellular level, and it is likely that multiple early neonatal phase [27] , is absent in adult ventricular switches exist in the process of hypertrophy [35] . Recent myocytes [17] , and is re-expressed during hypertrophy evidence suggests that the AT -mediated angiotensin II [18] . Its density is directly related to the severity of cardiac receptors is an appealing possibility, which requires further References experimentation. a heart where the substrate for reentry is certainly present. The observation that a sub-antihypertensive dose of
